Literature DB >> 20705381

Comparison between transumbilical and transabdominal ports for the laparoscopic retrieval of benign adnexal masses: a randomized trial.

Li-Yun Chou1, Bor-Ching Sheu, Daw-Yuan Chang, Su-Cheng Huang, Szu-Yu Chen, Wen-Chiung Hsu, Wen-Chun Chang.   

Abstract

OBJECTIVE: To compare the feasibility, operative time, specimen retrieval time, and effect on postoperative pain of laparoscopic retrieval of benign adnexal masses between a 10-mm transumbilical and a 10-mm transabdominal port. STUDY
DESIGN: Fifty women with adnexal masses who were scheduled for a laparoscopic procedure between July 2008 and April 2009 were enrolled. The patients were randomized into two groups; these were patients where a transumbilical port was used for specimen retrieval (transumbilical group, n=25) and patients where a transabdominal port was used for specimen retrieval (transabdominal group, n=25). Preoperative suspicion of malignancy and indications suggesting a need for hysterectomy or myomectomy were considered to be exclusion criteria. Randomization was centralized and computer-based. Patients recorded the severity of incisional pain on a visual analog scale (VAS) with 0 meaning no pain and 10 meaning unbearable pain.
RESULTS: There were no significant differences in age, body mass index, umbilical thickness, abdominal thickness, cyst size, cyst amount, cyst weight, histology, complications and duration of hospital stay when the two groups were compared. Patients in the transumbilical group had a significantly shorter specimen retrieval time (0.7 ± 1.8 min vs. 4.9 ± 12.6 min, p=0.006) and a significantly lower postoperative day (POD) 0 VAS pain score (5.2 ± 2.1 vs. 6.6 ± 2.2, p=0.015). Significantly fewer patients in the transumbilical group had a specimen retrieval time of ≥10 min (0% vs. 20%, p=0.025) and a POD 0 VAS pain score of >5 (36% vs. 84%, p<0.001). However, the average POD 1 VAS pain score (3.2 ± 1.8, vs. 3.6 ± 1.6) and the proportion with a POD 1 VAS pain score >5 (12% vs. 12%) were similar for the two groups.
CONCLUSION: When laparoscopic surgery on benign adnexal masses is carried out using a 10-mm incision wound, removal of the specimen via the umbilical port has a shorter retrieval time and produces less postoperative pain than retrieval via a lateral abdominal port.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20705381     DOI: 10.1016/j.ejogrb.2010.07.029

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

Review 1.  Transvaginal specimen removal in minimally invasive surgery.

Authors:  Panagiotis Kallidonis; Vasilis Panagopoulos; Iason Kyriazis; Marinos Vasilas; Evangelos Liatsikos
Journal:  World J Urol       Date:  2016-01-30       Impact factor: 4.226

2.  A systematic review on the cost evaluation of two different laparoscopic surgical techniques among 996 appendectomies from a single center.

Authors:  Noemi Zorzetti; Augusto Lauro; Samuele Vaccari; Alessandro Ussia; Manuela Brighi; Vito D'andrea; Maurizio Cervellera; Valeria Tonini
Journal:  Updates Surg       Date:  2020-05-30

3.  A novel technique for laparoscopic removal of the fallopian tube after ectopic pregnancy via transabdominal or transumbilical port using homemade bag: A randomized trial.

Authors:  Ali Akdemir; Ahmet Mete Ergenoğlu; Levent Akman; Ahmet Özgür Yeniel; Fatih Sendağ; Mehmet Kemal Oztekin
Journal:  J Res Med Sci       Date:  2013-09       Impact factor: 1.852

4.  Novel port placement and 5-mm instrumentation for robotic-assisted hysterectomy.

Authors:  Ceana H Nezhat; Adi Katz; Erica C Dun; Kimberly A Kho; Friedrich A Wieser
Journal:  JSLS       Date:  2014 Apr-Jun       Impact factor: 2.172

5.  Effect of laparoscopy by single-port endoscopic access in benign adnexal surgery: study protocol for a randomized controlled trial.

Authors:  Andy Schmitt; Patrice Crochet; Karine Baumstark; Claire Tourette; Sabine Poizac; Audrey Pivano; Léon Boubli; Ludovic Cravello; Aubert Agostini
Journal:  Trials       Date:  2018-01-15       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.